Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
1.410
+0.040 (2.92%)
At close: Apr 17, 2025, 4:00 PM
1.370
-0.040 (-2.84%)
After-hours: Apr 17, 2025, 6:35 PM EDT

Pasithea Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-13.9-15.96-13.94-2.17-0.06
Depreciation & Amortization
0.650.650.010-
Loss (Gain) From Sale of Assets
--0.07---
Stock-Based Compensation
0.770.590.841.22-
Other Operating Activities
0.080.40.36-2.33-
Change in Accounts Payable
-1.431.070.750.440.01
Change in Other Net Operating Assets
-0.090.50.1-0.33-0.01
Operating Cash Flow
-13.92-13.43-13.69-3.17-0.06
Capital Expenditures
--0.03-0.11-0.02-
Sale of Property, Plant & Equipment
-0.11---
Cash Acquisitions
---2.19--
Other Investing Activities
-0.32-0.63--
Investing Cash Flow
-0.4-2.93-0.02-
Short-Term Debt Issued
-0.39---
Total Debt Issued
-0.39---
Short-Term Debt Repaid
--0.39---
Total Debt Repaid
--0.39---
Issuance of Common Stock
0--57.240.42
Repurchase of Common Stock
--3.73---
Other Financing Activities
4.52--3.21-1.31-
Financing Cash Flow
4.52-3.73-3.2155.930.42
Foreign Exchange Rate Adjustments
-0-00.01-0.01-
Miscellaneous Cash Flow Adjustments
--0--
Net Cash Flow
-9.41-16.76-19.8152.720.37
Free Cash Flow
-13.92-13.46-13.8-3.2-0.06
Free Cash Flow Margin
----21216.05%-
Free Cash Flow Per Share
-12.70-10.97-10.93-6.14-0.16
Levered Free Cash Flow
-9-7.32-6.52-1.51-
Unlevered Free Cash Flow
-9-7.32-6.52-1.5-
Change in Net Working Capital
1.52-1.46-0.61-0.11-
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q